Cowen Remains Bullish Following Workday (WDAY) Q1 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- AI stocks lift Wall St as oil falls, Treasury yields decline
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- AMD stock jumps as chip rally builds ahead of summit
- Novo Nordisk shares drop as investor event disappoints
Canaccord Genuity Reiterate Buy Following Workday (WDAY) Q1
May 27, 2015 9:17 AM EDTCanaccord Genuity maintains a Buy rating on Workday (NYSE: WDAY), and cut the price target to $100.00 (from $110.00), following quarterly results. Analyst Richard Davis said that results showed upsides across the board. revenues of $251.0M, came in $6M ahead of estimates. Non-GAAP EPS beat estimates by $0.06.
Davis commented, saying, "We believe WDAY faces a decade of growth that... More
After-Hours Stock Movers 05/26: (EOX) (FPRX) (TIVO) Higher; (VNET) (WDAY) (COT) Lower (more...)
May 26, 2015 6:04 PM EDTEmerald Oil (NYSE: EOX) 53.6% HIGHER; elected not to proceed with its previously announced public offering of common stock. As a result of the Company's election not to proceed with its public offering, the Company will not be taking action to close the previously announced Delaware Basin acquisition.
Five Prime Therapeutics, Inc. (Nasdaq: FPRX) 20.2% HIGHER; bluebird bio (NASDAQ: BLUE) and Five Prime Therapeutics, Inc. (Nasdaq: FPRX) announced that they... More
Workday, Inc. (WDAY) Tops Q1 EPS by 6c, Offers Q2 Guidance
May 26, 2015 4:05 PM EDTWorkday, Inc. (NYSE: WDAY) reported Q1 EPS of ($0.02), $0.06 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $251 million versus the consensus estimate of $245.01 million.
Workday, Inc. sees Q2 2015 revenue of $270-274 million, versus the consensus of $272.39 million.
For... More
